Showing 841 - 860 results of 115,466 for search '(( a non decrease ) OR ( 5 ((((step decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 1.96s Refine Results
  1. 841
  2. 842

    Association summary of genome wide significant <i>BCL11A</i> SNPs from non-conditional and conditional regression analysis. by Siana Nkya Mtatiro (654940)

    Published 2014
    “…<p>Abbreviations: Chr: chromosome, SNP: single nucleotide polymorphism, ref allele: ancestral allele, alt allele: alternative allele, β-value (Beta estimate): the effect that a change in single allele has on HbF,-β indicate a decreasing effect. …”
  3. 843
  4. 844

    DataSheet1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.docx by Peng Cao (107508)

    Published 2022
    “…Creatinine clearance (CrCl) was identified as a covariate to CL, and ERCC1 (rs3212986) and CYP3A5 (rs776746) gene polymorphisms as covariates to Q. …”
  5. 845

    DataSheet1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.docx by Peng Cao (107508)

    Published 2022
    “…Creatinine clearance (CrCl) was identified as a covariate to CL, and ERCC1 (rs3212986) and CYP3A5 (rs776746) gene polymorphisms as covariates to Q. …”
  6. 846

    Table_1_Manipulation of an α-glucosidase in the industrial glucoamylase-producing Aspergillus niger strain O1 to decrease non-fermentable sugars production and increase glucoamylas... by Wenzhu Guo (501328)

    Published 2022
    “…The results showed the transglycosylation product panose was decreased by more than 88.0% in agdA/agdB double knock-out strains than strain O1. …”
  7. 847

    Requirement of NF-κB activation for cytokine-mediated reductions in TEER. by Paul R. Clark (714064)

    Published 2015
    “…F: Effects of SR-IκB dominant negative overexpression on IL-1β-leak (ECIS). Note that IL-1β over a 12 hour time course was ineffective at decreasing TEER in SR-IκB-transduced HDMEC. …”
  8. 848

    Vitamin A supplementation reduces the Th17-Treg – Related cytokines in obese and non-obese women by Mahdieh Abbasalizad Farhangi (7513307)

    Published 2018
    “…The mean concentrations of IL-17 and TGF-β were significantly decreased after vitamin A supplementation in non-obese and obese women respectively. …”
  9. 849
  10. 850
  11. 851

    Decreases in white matter integrity in t(1;11) translocation carriers (n = 7) versus non-carriers (n = 13) and in patients (n = 34) versus controls (n = 33). by Heather C. Whalley (287657)

    Published 2015
    “…To aid visualization the results (pfwe < 0.05) are thickened using the “tbss-fill” command. Statistics for FA decreases in the patient group versus controls for these peaks; cluster 1: p = 0.023 at [-3, 28, 6; left genu of corpus callosum], cluster 2: p = 0.032 at [29, 26, 15; right fronto-occipital fasciculus], cluster 3: p = 0.012 at [11, 26, 14; right genu of corpus callosum], cluster 4: p = 0.033 at [20, 25, 0; right acoustic radiation], and cluster 5: p = 0.031 at [28, -24, -8; right fornix] i.e. for clusters 1–5 respectively, see, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0130900#pone.0130900.t002" target="_blank">Table 2</a>).…”
  12. 852

    Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice - Fig 5 by Mari Merentie (4781907)

    Published 2018
    “…<p><b>VEGF mRNA and protein levels in naïve/non-transduced mouse endothelial cells (a-b) and cardiomyocytes (c-d) <i>in vitro</i> after dox treatment of 10–1000 ng/ml for 24–72 h.…”
  13. 853
  14. 854
  15. 855
  16. 856

    Sensitivity of the optimal pathway to increased and decreased discounting (5% and 0%), to the addition of other non-cardiovascular health care costs in added years of life, the measurement of health gain in QALYs rather than DALYs, and to a reduction in the cost of statin drugs to the much lower price in New Zealand (NB. the order of interventions is altered only by the reduction in statin price, with statins becoming a more cost-effective intervention option than the blood pressure-lowering drugs). by Linda J. Cobiac (149055)

    Published 2012
    “…<p>Sensitivity of the optimal pathway to increased and decreased discounting (5% and 0%), to the addition of other non-cardiovascular health care costs in added years of life, the measurement of health gain in QALYs rather than DALYs, and to a reduction in the cost of statin drugs to the much lower price in New Zealand (NB. the order of interventions is altered only by the reduction in statin price, with statins becoming a more cost-effective intervention option than the blood pressure-lowering drugs).…”
  17. 857
  18. 858
  19. 859
  20. 860